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Symptoms of psychosis such as hallucinations and delusions can be intrusive and
unwanted and often remain treatment-resistant. Due to recent progress in basic and
clinical sciences, novel approaches such as sleep-based interventions are increasingly
becoming offered to address the physical and mental health issues of people with
severe mental illness. While the primary outcome is to improve sleep, studies have
demonstrated that interventions that target symptoms of insomnia can also produce
improvements in the severity of psychotic symptoms, quality of life, and functional
outcomes. This study presents qualitative data on the attitudes and preferences of
people with schizophrenia and schizo-affective disorders to three different types of
therapies for insomnia (standard pharmacological, melatonin-based, and cognitive
and/or behavior therapy). Interviews included discussions regarding the perceived
advantages and limitations of different therapies, enablers to taking up the preferred
option, as well as personal strategies that have helped respondents with sleep problems
in the past. Results showed that, when given the choice, these individuals prefer
psychological and behavioral-type therapy to other sleep interventions because of its
potential to support and empower them in taking responsibility for their own recovery.
Pharmacological therapies, by contrast, are viewed as useful in managing acute sleep
problems, but only as a short-term solution. Overall, the findings underscore the need
for patients’ active engagement when making decisions about treatment options.
Keywords: sleep disorders, sleep, insomnia, psychological treatment, CBT,melatonin, antipsychotics, neuroleptic
Introduction
The term ‘psychosis’ refers to a set of experiences which include hearing voices and seeing images
that other people do not (‘hallucinations’) and unusual beliefs that others do not share (‘delusions’).
These symptoms often attract a psychiatric diagnosis such as schizophrenia, schizoaﬀective
disorder, bipolar disorder, or other psychotic disorders. Symptoms related to psychosis can
be particularly distressing and burdensome, and can persist despite intensive and prolonged
treatment, prompting the need to explore alternative interventions.
Frontiers in Psychology | www.frontiersin.org 1 July 2015 | Volume 6 | Article 990
Waters et al. Preferences for insomnia treatment in psychosis
Sleep has been an area of increasing interest in the treatment
of mental illness such as depression (Hickie et al., 2013) and
more recently in the treatment of psychotic disorders (National
Institute of Mental Health [NIMH], 2015). Insomnia is a
particularly common condition with heterogeneous origin and
which aﬀects almost all individuals with psychosis at some point
during their illness (Donlon and Blacker, 1975; Benca et al., 1992;
Chemerinksi et al., 2002; Chouinard et al., 2004). Symptoms
include highly irregular timing of sleep–wake patterns, diﬃculties
getting to sleep or staying asleep, and being active at night
and excessively tired during the day. Studies have demonstrated
that these sleep problems are intrinsically linked to the cause
and maintenance of psychotic symptoms (Zarcone and Benson,
1997; Yang and Winkelman, 2006; Waters et al., 2011) and
to psychotic relapse (Heinrichs and Carpenter, 1985; Falloon,
1992). Individuals with psychosis and co-occurring sleep–wake
problems are also more likely to have cognitive impairments,
negative mood, reduced perceived ability to cope, daytime
dysfunctions (Zarcone and Benson, 1997; Chemerinksi et al.,
2002; Hofstetter et al., 2003; Chouinard et al., 2004) and an
increased risk of suicide (Pompili et al., 2009).
In response to these ﬁndings, speciﬁc strategies which target
poor sleep in psychosis are increasingly being developed with
a view to improve sleep, but also to treat psychotic symptoms
(e.g., Edinger et al., 2009; Myers et al., 2011; Wagley et al.,
2013) and ameliorate clinical outcomes and functional disability
(e.g., Suresh Kumar et al., 2007). The evidence-base, however,
only so far includes small pilot studies, and there are no
clear recommendations regarding the most eﬀective treatment
approach for insomnia in psychosis. In addition, questions
remain regarding the extent to which these individuals are likely
to take up sleep therapies.
Recovery-oriented practices advocate for individuals to be
actively involved in decision-making about available intervention
options, yet people living with schizophrenia and psychosis may
not be given many choices or may ﬁnd themselves unheard
by mental health professionals in treatment planning and care
(González-Torres et al., 2007). If interventions for insomnia
are to be a viable treatment option, a key ﬁrst stage must
be to seek the personal perspectives of people with psychotic
disorders regarding their preferences for diﬀerent types of sleep
interventions.
In this study, we sought to understand the preferences of a
sample of individuals with psychosis regarding diﬀerent types of
therapies for insomnia. Qualitative interview methodology was
used in the current study to identify preferred choices amongst
diﬀerent alternatives (‘testing alternatives’ analytic framework),
and to identify issues of personal importance with regards to
taking up these therapies (‘key concepts’ framework). Qualitative
methods are often utilized to conduct in-depth inquiries into
a speciﬁc issue and have considerable explanatory power when
seeking to understand personal perspectives that cannot be
comprehensively addressed using quantitative measures. New
knowledge is generated through the analytical examination of
narratives in response to semi-structured interviews. Typically,
interviews and focus groups are conducted until the same themes
keep re-emerging (a state of ‘saturation’). Thus, sample sizes in
qualitative studies are typically much smaller than cross-sectional
studies (and can be as small as n = 1). The lived experience
of people with psychosis has previously been examined using
such qualitative methodologies and studies show that these
individuals are highly capable of engaging in this style of
interviewing and providing informed opinions (Holmes et al.,
1995).
This paper presents a report on the views and preferences of
a sample of individuals with a diagnosis of schizophrenia
and schizoaﬀective disorders regarding three diﬀerent
types of evidence-based therapies for insomnia: standard
pharmacological, melatonin-based, and psychological and
behavioral-type (talking) therapies. The interviews included
discussions of (i) the perceived advantages and limitations of
each therapy, (ii) preferred approaches, (iii) enablers to taking
up the preferred therapy, and (iv) personal strategies that have
helped these individuals with sleep problems in the past. Before
the results are presented, an overview of the diﬀerent treatments
available, their evidence-base and their mechanisms of action,
are presented.
Insomnia Treatments Available for
Psychosis
Diﬀerent types of interventions are available to treat sleep
dysfunction in psychosis. Some are based on techniques
known to be eﬀective in community samples and others
are informed by an analysis of sleep–wake behaviors. The
most commonly used interventions to regulate sleep–wake
patterns and improve symptoms of insomnia include (1)
standard pharmacotherapy, (2) melatonin, and (3) psychological
and/or behavioral interventions. Other interventions exist (e.g.,
bright light therapy, stand-alone sleep restriction therapy) but
insuﬃcient evidence exists for their use in psychosis or they are
not recommended due to a possible association with psychotic
relapse (e.g., Sit et al., 2007; based on case study in bipolar
disorder).
Pharmacotherapy
A common clinical approach for managing insomnia in psychosis
uses pharmacotherapy, with options including antipsychotics
and hypnotics. The appeal of pharmacotherapy is its relatively
rapid onset of action (Hickie et al., 2013) and sedatives and
hypnotics are frequently prescribed for acute sleep problems
(Falloon et al., 1996).
With regards to antipsychotics, the inhibitory eﬀects of
these drugs on dopamine (DA) transmission are thought to
represent a likely mechanism for producing sedation. While
antipsychotics are not recommended as a direct treatment for
sleep disturbance in clinical guidelines, a common perception
amongst mental health staﬀ is that antipsychotics can satisfactory
addresses both symptoms of psychosis and chronic insomnia.
Indeed, many patients report immediate symptom relief, but
empirical evidence regarding the sleep-promoting eﬀects of
antipsychotics remains mixed. For example, improvements in
total sleep time, sleep eﬃciencies and stage 2 sleep have been
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reported (Monti and Monti, 2004) but sleep problems persist
(e.g., Keshavan et al., 1996; Lieberman et al., 2005), with
antipsychotic medication accounting for less than 10% of the
total variance in sleep quality (Waters et al., 2012). Another
factor of central importance includes the undesirable physical
and somatic side eﬀects of antipsychotic medications such as
grogginess, next day tiredness, as well as diﬃculties getting to
sleep or sleeping too much (e.g., Morrison et al., 2000; Ritsner
et al., 2002).
Melatonin
Melatonin (ingested as daily capsules) is commonly oﬀered
for the treatment of insomnia and other disturbances of the
sleep–wake cycles in the general community. Melatonin is a
natural hormone secreted by the pineal gland which acts to
stabilize circadian rhythms. The sedative and chronobiologic
eﬀects of melatonin have led to its popular use as a treatment
for insomnia, jet lag, circadian rhythm sleep disorders as well
as in mood disorders. Melatonin produces fewer side-eﬀects
than antipsychotics, although it can be linked to headaches and
drowsiness in higher dosages.
Given alterations in circadian chronobiologic rhythms of
melatonin (phase advance, and low output) in individuals with
schizophrenia-spectrum disorders (Van Cauter et al., 1991; Rao
et al., 1994), melatonin appears to be a promising treatment
option for insomnia. In support, studies provide some evidence
for the beneﬁcial eﬀects of melatonin in this clinical group.
Suresh Kumar et al. (2007), for example, conducted a randomized
trial of melatonin versus placebo with 40 individuals with
schizophrenia using ﬂexible dose 3–12 mg of melatonin for
2 weeks as an adjunct to regular medication. Relative to placebo,
melatonin had some beneﬁts on night-time awakenings and
sleep duration as assessed by questionnaires (small eﬀect size),
and was also linked to improvements in mood and daytime
functioning. Using a smaller dose of 2 mg of melatonin and a
sample of 19 individuals with schizophrenia in a randomized,
double-blind, and cross-over design, Shamir et al. (2000)
demonstrated that melatonin treatment for 3 weeks was linked
to improved sleep eﬃciency and sleep duration, as well as
reduced duration to sleep onset, although these improvements
were mostly observed in people whose sleep quality was low at
baseline.
Psychological and Behavioral Interventions
(Including CBT)
Neurobiological changes can explain many of the sleep
problems in psychosis (e.g., Van Cauter et al., 1991; Rao
et al., 1994), although sleep habits and psychological problems
also contribute signiﬁcantly to the onset and maintenance
of insomnia. For instance, precipitating factors for insomnia
often include stressful life events, and there is a wealth of
evidence demonstrating that psychological issues such as worry
and rumination, and cognitive factors such as dysfunctional
beliefs and thought control strategies, perpetuate symptoms of
insomnia in the general community (Harvey, 2002). Therefore,
management strategies which target psychological, cognitive, and
behavioral factors that prevent suﬀerers from re-establishing a
normal sleep pattern have recently been the subject of much
attention.
Components of cognitive interventions target cognitive
hyperarousal, maladaptive thought control strategies,
dysfunctional beliefs and attitudes such as the perceived need to
control sleep, and relaxation elements. By contrast, behavioral
interventions focus on the formation of good sleep habits (a
regular wake time, not clock watching, managing caﬀeine, and
alcohol intake), breaking negative associations of the bed as a
place of frustration, and awareness of sleep-promoting activities
such as regular exercise. The beneﬁts of such approaches to
insomnia in the general population are well documented (e.g.,
Harvey et al., 2014).
Some therapeutic approaches include behavioral interventions
alone (e.g., sleep restrictions), although studies in the (non-
psychiatric) community show that therapies that address
both behavioral and cognitive elements (‘Cognitive–Behavioral
Therapy for Insomnia, CBT-I’) have the most potential in
producing reliable and durable changes (Spielman et al., 1987;
Perlis et al., 2005; Schmidt et al., 2011).
Individuals with psychosis often have a sedentary lifestyle and
a lack of daytime structure (Hofstetter et al., 2003), suggesting
that behavioral approaches promoting good sleep, regular
sleep routine, and contributors to daytime sleepiness can
therefore increase awareness about the need for behavioral
changes. We recently demonstrated evidence of knowledge gaps
about sleep hygiene in inpatients with psychosis, speciﬁcally
regarding the importance of regular sleep–wake timings
and the wake-promoting eﬀects of nicotine (Chiu et al.,
2015a, in 55 inpatients with psychotic disorders). In addition,
these psychiatric individuals demonstrated levels of thought
control strategies (rumination and aggressive suppression)
and dysfunctional beliefs about sleep (preoccupation about
the consequence of poor sleep) that were similar to non-
psychiatric controls insomnia, suggesting that interventions
combining cognitive and behavioral strategies (such as CBT-
I) are likely to be most eﬃcacious for treating insomnia in
psychosis.
While CBT-I is recommended by the American Academy of
Sleep Medicine as a ﬁrst-line treatment for insomnia (Espie,
2009), few studies has been published in people with psychosis.
Myers et al. (2011) provided four individual CBT-I sessions to 15
patients with persisting persecutory delusions and insomnia. It
was reported that participants reported signiﬁcant improvements
in self-reported sleep quality as well as reductions in delusions
and psychological distress at post-intervention and one month
follow-up, providing ‘proof of concept’ for CBT-I in psychosis.
Other studies have reported on the eﬀectiveness of cognitive and
behavioral interventions, although these other studies included
mixed diagnostic groups with primarily aﬀective or anxiety
disorders (Edinger et al., 2009;Wagley et al., 2013) or abbreviated
treatment components (one session Lyne et al., 2011; two sessions
Wagley et al., 2013).
Overall, a number of interventions may be used to improve
sleep and symptoms for people with schizophrenia and related
psychoses. The current paper now presents a study of their
preferences regarding these interventions.
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Qualitative Study into the Views and
Preferences of Respondents Regarding
Three Different Types of Insomnia
Treatments
In this section, the views and preferences of a sample of
individuals with schizophrenia and related psychoses with
regards diﬀerent types of evidence-based therapies for insomnia
are presented. The interviews included discussions of (i) the
perceived advantages and limitations of these therapies, (ii)
preferred approaches, (iii) enablers to taking up the preferred
therapy, and (iv) personal strategies that have helped them with
sleep problems in the past.
Participants
Participants were recruited from Graylands Psychiatric Hospital
(inpatient wards) and a local mental health drop-in centre (The
Lorikeet Centre). Recruitment occurred using advertising and a
snow-ball technique. A total of 14 respondents completed this
study (aged 28–64; 50%males). In keeping with previous research
conducted with this population (Carey et al., 1999), the aim
was for focus group with sizes of three to four people. Three
focus groups (comprising up to four people), and six individual
interviews for individuals who preferred not to engage in groups
were conducted between November 2013 and January 2014.
All individuals had been given a diagnosis of schizophrenia
or schizoaﬀective disorder by a mental health physician,
and all participants had substantial past or current sleep
problems accompanied with daytime dysfunction. Length of
illness since ﬁrst hospitalization ranged from three to 33 years
(mean = 16 years). All participants were taking one or more
antipsychotic drug; three were also taking benzodiazepines, and
ﬁve antidepressants. All had a prior experience of sedative and/or
benzodiazepine. One participant had received sleep hygiene
information in the past (delivered informally by a mental health
professional). Two had tried melatonin, and one (ID4.1) was still
taking melatonin, but none had received CBT-I. Ethical approval
was granted by the University of Western Australia and North
Metropolitan Health Service – Mental Health Human Research
Ethics Committees.
Methods
Focus groups followed standard procedures (Morgan et al.,
1998). Focus groups and individual interviews were conducted by
psychologist VC at the drop-in centre or at Graylands Hospital.
Oversight was provided by a senior team member (FW or MR)
to ensure that the procedures were applied consistently, that
participants had suﬃcient time and opportunities to give their
views and that in-depth discussions were pursued. Groups began
with an introduction, including conditions of conﬁdentiality
and respect for one another, followed by the methods and
rationale of the project. Topics were addressed in a ﬂexible way
using a semi-structured interview schedule developed by the
investigators. In Part 1, personal experiences of sleep problems,
help seeking behavior, therapies that had been tried (including
standard pharmacologic), and personal strategies that helped in
the past were addressed. In Part 2, a handout was provided with
information about melatonin and cognitive/behavior therapies
drawn from the literature and consumer medicine information.
No handouts were provided for pharmacological therapies since
all participants had prior experience of antipsychotics and
sedatives. Discussions focused on the perceived beneﬁts of
diﬀerent therapies (‘what do you like most?’) and limitations
(‘what do you like least?’), preferred approaches for addressing
sleep problems in the short term and in the longer term, and what
would help them to take up the preferred interventions. Prompts
were used to aid discussion and encourage participants to follow
on from previous comments. After the consent and introduction,
discussions lasted 45–60 min.
Analysis of Transcripts
Sessions were recorded on audio tape, and then transcribed using
Krueger and Casey’s (2000) approach to sorting transcript data.
Two researchers (VC and FW) made themselves familiar with
the content of transcripts. VC then coded the transcripts, and
sorted the coded data into categories and subcategories in excel
document spreadsheets (descriptions of sleep problems, impact,
coping, treatment types, enablers, personal strategies) which were
veriﬁed by the other researchers (FW andMR). Next, the research
team analyzed the spreadsheets independently and then met to
compare and discuss the coded data and whether some categories
should be combined or separated until a consensus was reached.
No diﬃculties in coding were met and interrater agreement
was high with no disagreements arising on the main ﬁndings.
The joint discussions also allowed team members to reﬂect on
their views of the research, and the representation of multiple
specialists in the team allowed an analysis and interpretation of
the data without any systematic biases. Credibility checks were
conducted with additional consultation with a study participant
and with the input of person with a lived experience.
Results of the Qualitative Study
Interviews
Attitudes Toward, and Preferences for,
Different Types of Insomnia Therapies
Using the systematic analysis described above, reports were
pooled separately for the diﬀerent interventions. Overall, the
respondents had ﬁrm opinions about the diﬀerent sleep
treatments (see Table 1 for summary).
Table 1 shows seven elements which participants identiﬁed as
valuable in a sleep therapy andwhich address not only sleep issues
(routine, long-term solution), but also physical health (drug-
free), psychological health (worry, stress, intrusive thoughts, and
social contact) and principles sustaining recovery (regaining
control, and learning something new). Cognitive and behavioral
therapies met all seven criteria and was rated as acceptable by 71%
of participants, melatonin met one criterion (acceptable in 57.2%
of the sample), and pharmacotherapy none (acceptable by only
22.5% of participants).
Six elements were then identiﬁed as unwanted in therapy:
lack of conﬁdence in its evidence base; risks associated with
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polypharmacy; side eﬀects from medications (cognitive and
functional eﬀects); and lack of choice and control over the
process. Lack of motivation was also perceived as a barrier to
engaging in therapy. Pharmacotherapy met 4/6 (66%) of these
unwanted elements, melatonin 3/6 (50%), and cognitive and
behavioral therapies 2/6 (33%).
Pharmacotherapy
Respondents reported mixed feelings about their medications,
and had both positive and negative opinions about
pharmacological approaches to sleep treatment. Six respondents
(42.8%) felt that medications had helped with their sleep
problems:
(ID7.1) Well I went to the psychiatrist and she prescribed me
antipsychotics and I went to sleep after that.
(ID4.1) I’d like to have been on something else, like temaz just for a
little while to cover the time so I can have a decent night’s sleep.
A majority (n = 11, 78.5%) however, did not view
pharmacotherapy as an acceptable intervention. Reasons
included unwanted side eﬀects and possible interactions between
drugs (n = 7, 50%):
(ID8.2) I was just about to say, sometimes it takes about 11 or
12 hours I’ve noticed with some medications to wear oﬀ enough to
be alert you know what I mean?
Other reasons were that the medications didn’t always help
with sleep problems (42.8%), or that their physicians were often
changing the type, dosage or scheduling of medications, which
impacted on their sleep:
(ID6.1) I couldn’t sleep for weeks . . . the doctor in her wisdom
decided to change my medication; They’re always juggling with
it in the clinics, and I’ve had to put my foot down – no more
juggling unless there’s a really good reason for it, I don’t wanna be a
guinea pig.
Melatonin
Respondents’ views of melatonin were largely favorable. Six
respondents (42.8%) were drawn by its novelty and had not heard
of other people using it:
(ID1.2) Probably it’s just something new. You wanna try something
new, see if it will help me go to sleep.
More than a quarter of the sample (n = 4; 28.5%)
viewed melatonin as a more natural and safer option than
pharmacotherapy:
(ID9.1) If you’re giving melatonin works better than a sleeping
tablet, it’d be a more natural option.
(ID6.1) Well I know that melatonin’s natural and it is something
natural.
While melatonin was perceived to be ‘more natural’ than
pharmacotherapy, it was still viewed by many as another drug
option, and thus potentially harmful. Six participants (42.8%) did
not want to take more medications than they needed to:
(ID2.1) Aw the thing is I don’t. . .I take plenty of medications and I
wouldn’t want to take any more than I have to. . .
(ID3.2) Yeah that’s the thing, like you know, for years with me like
I’d take tablets, a side eﬀect pill to counteract that, and injections
too. . . and now I’m down to just a couple of tablets at night and
I don’t want to go back to scoﬃng down pills and getting jabs you
know
A sizeable minority also worried about possible side eﬀects
(n = 6, 42.8%), particularly relating to headaches and tiredness,
and the interaction melatonin might have with other drugs:
(ID4.1) I’d rather not be on melatonin if it can cause headaches or
drowsiness.
(ID1.3) What if it clashed with the other medication that we’re
taking?
Cognitive and/or Behavioral Interventions
Discussion of non-pharmacologic interventions brought up a
greater number of positive than negative points, and a quarter
of respondents did not raise any negatives views toward cognitive
and behavioral interventions (29%).
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Half of all respondents (50%) agreed that a beneﬁt of such
treatment was that it was a drug-free option:
(ID3.1) Because it doesn’t include much of the things with
medications. I get some pretty bad things with side-eﬀects.
(ID5.1) Learn to know yourself better, because spend time to think
about what aﬀects you or not, something good for you, natural way.
However, a quarter of respondents (n = 4; 28.5%) were
skeptical regarding whether it could oﬀer something new that
they had not tried before, or stated that ‘talking’ had limited
eﬃcacy on sleep problems:
(ID5.2 ) yeah cause I’ve tried a lot of like CBT kind of stuﬀ, and what
else. . . yeah I’ve tried heaps of stuﬀ. I got into Buddhism like full on,
and I was meditating every day, and guided visualizations. . . all
that sort of stuﬀ, and it doesn’t seem to do anything.
Being actively engaged in the treatment process was a beneﬁt
of cognitive/behavior therapy for 50% of respondents, who felt
that being involved in the treatment process would give them a
sense of control and autonomy:
(ID1.3) Like working at it and doing.. you know. . .what we’ve been
told. . .working at it. Like trying to help yourself.
(ID3.2) But if you said, like it’s a test and you make that decision
and that’s what you want to do, then that’s your decision, your
control. . .so it’s a bit of a plus there. Yeah I think that’s pretty much
a human element isn’t it?
The majority of respondents (57.1%, n = 8) understood that
the aims were to establish a good sleep routine and to promote
long-lasting changes in sleep behavior.
(ID6.1) Yeah. I’d give it all I had you know, because I’ve grown to
understand what it. . .I’m looking to break the bad sleeping habits
really. It probably works better in the long term, I think, because
what you learn stays with you. . . well that might be my experience.
Sleep problems in psychosis are often related to worries,
stress, and anxiety. Respondents stated they would value therapist
advice on how to deal with stress and racing thoughts (28.5%,
n = 4). Learning to relax was also perceived to be a valuable skill
by four participants (28.5%):
(ID1.2) They’ve got a progressive one which relaxes your muscles
from there down to your feet which is very, very good
Conversely, two participants (14.3%) worried those
psychological therapies for sleep may bring up traumatic
issues;
(ID1.2) Well it might be a bit unsettling too. . .Well it might stir up
too much stuﬀ that you can’t deal with. Yeah, there’s people who
may be sensitive to it.
Finally, face to face interaction, and the sharing of personal
experiences, was seen to be of therapeutic beneﬁt for four
respondents (28.5%):
(ID8.2) I used to ring helplines and things like that. I’ve had friends
too who have rung me at odd times of the night. I think sometimes
all you need is some conﬁrmation you’re human, you’re alive.
(ID4.1) About life issues, about problems, you can keep people calm,
not be frightened of sharing your thoughts, to have understanding
of one another.
Challenges for 42.8% of participants (n = 6) included
the discipline, time and hard work that is required for the
psychological therapy. The motivation needed to repeatedly
attend the sessions and actively engage in treatment was also
voiced as a limitation by ﬁve (35.7%) of the respondents:
(ID5.2) You see my biggest problem is my motivation, I’m not very
motivated. I’m told that that’s part of something to do with the
frontal lobe or something like that where it aﬀects my motivation,
but I’m not sure if that’s sleep-related or not
Participants’ Views Regarding How to Best
Support their Sleep
Preferred Approach
Participants were asked to reﬂect back on their journey with
mental illness and to describe the type of insomnia treatment they
would chose if they had been given the choice.
One dominant opinion (57.1%, n = 8) was that one approach
might not ﬁt everyone, all of the time. Speciﬁcally, a treatment
might work for one person but not another, and also that some
interventions work better at some stages of the illness or recovery
than others. Particularly, during the acute phase of the illness,
pharmacological approaches might work best:
(ID6.1) In those days, I was just hopelessly entwined in my illness
and I thought I was alright, but looking back like. . .
(ID5.1) Sometimes I can’t work by myself, don’t know why and only
the medicine can keep me in routine.
Respondents also suggested that psychological and behavioral
interventions should be the ﬁrst line treatment, with a focus on
sleep education, relaxation techniques and having someone to
speak to, and with pharmacological options available if cognitive
and behavioral sessions do not seem to be improving their sleep.
(ID2.1)When that person starts getting aggravated and saying “this
isn’t working” And then they start getting aggro “I can’t sleep, f ∗∗
oﬀ, and I can’t do this anymore”, that’s maybe when the medication
should come in. But it should be kept at a bareminimum, you know,
only like you know if they use it once every 5 days that would be
really good you know.
Enablers of Psychological and Behavioral Therapies
for Sleep Problems
With cognitive and behavioral therapies as the preferred option,
we asked participants about factors that might enable and support
them in taking up such therapies. Table 2 shows that participants
provided a wide range of solutions.
Solutions were broken down into ﬁve main themes. The
ﬁrst theme relates to access to information in a language that
is easy to understand, and which addresses sleep issues that
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are directly relevant for people with symptoms of psychosis.
Therefore, studies which seek to understand the perspective
and personal experiences of people with lived experience, in
their own words, are better able to identify gaps in knowledge
and deﬁne clinical targets. For instance, our recent work
with groups of people with psychosis suggests that night-
time rumination, worries, hallucinated voices, external locus of
control (Chiu et al., 2015a), as well as frequent nightmares,
night terrors (Chiu et al., 2015b) are key experiences which
prevent good sleep from happening. In other words, while
better sleep is an objective, targets for treatment should
ﬁrst address factors that get in the way of achieving this
objective.
Themes 2 and 3 address some of the beneﬁts of therapies
from a personal perspective, and using the group format as
a productive conduit. First, sleep improvements are linked
to broader psychological improvements which include feeling
better, reduced tiredness and increased energy, all of which
provide motivation to persevere with the therapy. Second,
group interventions are perceived as advantageous by providing
opportunities to contribute and learn as a valued member of
their community. The opportunity to talk to and learn from
others was important for many participants, who reﬂected
that each individual has a personal and unique journey
which can be meaningfully shared with others facing similar
issues.
Theme 4 relates to overcoming personal challenges and the
hard work necessary to make changes in sleep habits and
cognitions that support good sleep. The ideas raised were
drawn from each individual’s experience in ﬁnding their own
personal strengths – some learnt to ‘let go,’ others to ‘self-talk,’
or ‘conduct rituals.’ These self-reﬂections make psychological
therapies particularly suitable for addressing sleep problems (as
opposed to the use of melatonin or pharmacological therapies
alone) given that they provide a space for the person to ﬁnd their
strengths and personal strategies as guided by an experienced
therapist.
Finally, theme 5 relate to practical issues about attending the
sessions. One participant raised the need for transport assistance
to attend the session. Financial hardships experienced by people
with psychosis on a pension are a common problem, and can get
in the way of these individuals receiving the right treatment and
at the right time.
Strategies that have Helped with Sleep Problems or
for Going Back to Bed
Finally, participants’ strategies that had been found to support
their sleep were solicited (Table 3). Sleep tips are now widely
available on the internet and popular media (for example
the Sleephealthfoundation.org.au) and from general and sleep
practitioners. Yet few are written for people with psychotic
disorders, and by people who themselves experience psychosis.
Although the current participant group had not received any
coaching or formal sleep education, their strategies closely
followed those recommended for community populations such
as the importance of winding down, relaxation, and regular
bedtimes.
Negative thoughts at bedtime were commonly brought up as
needing coping strategies. Worries and intrusive and ruminative
thoughts are a common feature of psychotic disorders (Morrison
and Baker, 2000) and are particularly elevated in those with
symptoms of insomnia (Chiu et al., 2015a). It is thus particularly
TABLE 2 | Enablers to psychological sleep therapies.
Main themes Enablers
(1) Information that is relevant to people
with psychosis
• Knowing that it would improve sleep
• I think hearing about the success rates. Hearing. . . the outcomes would make people wanna go more
• Make the sessions and the instruction content easy to understand
• I think it should be worded in such a way that I would understand
(2) Sleeping better is linked to feeling
better
• The biggest motivation is the intrinsic improvement
• Yeah, if you see improvement it will help you stick to it
• It’s good to have things to look forward to. . .you know, like once you get your rest either way, you’ll start feeling
better, you’ll think better, you’ll have more energy, and yeah umm...
(3) Empowerment and teaching others • If one person’s motivated, maybe someone else will get motivated and, if you’re lucky, half the people get into it
• Just adding to my general knowledge base you know, and being able to help other people
• Being able to talk about the experience of doing it and what worked for me, and maybe consider if they make the
judgment of what might work for them
(4) Overcoming personal challenges • Learn how to let go so that I can sleep; you know, let go mentally and physically so I can sleep, that would be the
overriding thing.
• Yeah well probably self-talk would come into it, because I know if I can talk myself into getting out of bed early, it’s a
big hurdle to overcome – that’s one of my bad habits. . .
• Like take your medication at a set time, do some sort of ritual
• There are lots of stumbling blocks, but I’m just learning how to use my brain now. I have... was in and out of hospital
for at least 5 years with no drugs, no crime. . . and uh that helped a lot with everything
(5) Practical issues • Well little things like catching a taxi motivated me to come today. Um so just, just um... just making things easier
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TABLE 3 | Personal strategies that have helped with sleep problems and
for getting back to sleep.
Routine
• A routine before bed like a ritual that is repeated every night
• Drinking milk before going to bed
• Reading a book
• Take a bath
Sleep hygiene
• More exercise during the day
• Quitting smoking and drugs
Relaxation
• Relaxation methods like meditation
• Relaxing music
Addressing negative thoughts
• Write in a book what you are thinking before you go to bed
• Do some art before going to bed to resolve an issue
• Doing an activity that breaks the train of thoughts that is going through
your mind which is stopping you getting to sleep
Feeling supported emotionally
• Ring the Samaritans so that I can tell someone what is on my mind, and I
feel validated
• Talking to someone
important that these individuals ﬁnd strategies that address these
psychological issues. Since CBT-I is the only type of therapy
which speciﬁcally addresses negative thoughts at bedtime, this
particular sleep intervention appears particularly well suited to
address the needs of this population.
Finally, social and psychological support (‘feeling supported’)
is often taken for granted by people in the community. One
participant suggested ringing helplines as a way to meeting one’s
psychological needs and reassurance, and achieving better sleep.
Summary and Discussion
This paper examined the views and attitudes of people with
psychosis about diﬀerent treatments for insomnia. This study
demonstrated, yet again, that people with severe and persistent
mental illness are perceptive and insightful and must to be
consulted about their treatment and care.
Respondents expressed mixed feelings about
pharmacotherapy. Many felt that antipsychotic and sedative
medications had beneﬁted their sleep, although concerns
remained about side eﬀects, particularly next-day drowsiness,
poor attention, and concentration. This supports recent ﬁndings
reporting on the side eﬀects of antipsychotics on concentration,
memory, tiredness, and restlessness (Morrison et al., 2000) and
of the distress caused by these reactions (Finn et al., 1990).
A majority of participants responded positively to melatonin
as a sleep treatment option, and amajority said they might try it if
given the opportunity. Its unfamiliarity, however, led to concerns
about how it might interact with their other medications and
other side eﬀects.
In the decisional balance, psychological and behavioral-
type therapies were perceived as more attractive and with
the potential to have greater sleep, psychological, physical,
and recovery beneﬁts than any other type of intervention,
and the majority of respondents favored this approach over
the others. The dominant view was that such therapies have
the potential to support and empower these individuals to
take responsibility for their own lives and their recovery.
Participants noted that the learning process regarding how
to manage sleep, and how to cope with sleep problems,
provides the only approach to a long-term solution to their
sleep problems. This acknowledges that these individuals are
experts in their own lives, and that they should be given
ownership and responsibility for their choices with appropriate
support.
While some respondents were skeptical regarding the
potential of such therapies to help with their sleep, many
were drawn to psychological support as a way of addressing
stress, worries, and racing thoughts. Ambivalence regarding the
value of CBT by clients with psychosis has been described
previously. In Messari and Hallam (2003), clients expressed
skepticism regarding the beneﬁts of the therapies for improving
symptoms but, at the same time, they valued the educational
components of the program and their relationship with the
therapist. This suggests that doubts should not be perceived as
a barrier for engaging in treatment as multiple beneﬁts might
arise, including psychological improvements with downstream
eﬀects on sleep (Franzen and Buysse, 2008). In further support
for ‘talking’ therapies, opportunities for human contact and
emotional support were also high on the list of enablers for
taking up therapy. It is often forgotten that many people with
psychosis live alone and experience substantial loneliness. Two
participants in this study, for instance, reported telephoning
helplines in the middle of the night to achieve this basic
human need. Psychological therapies are therefore highly suited
to address these concerns which can act as a barrier to good
sleep.
Lack of motivation was recognized as a possible barrier to
engaging in psychological and behavioral therapies. Lack of
motivation is a well-known symptom of psychosis (e.g., Bentall
et al., 2010) which likely impacts on cognition and take-up
of therapies (Gard et al., 2009). This suggests that therapies
that include motivational methods to engage clients maintain
treatment adherence and maximize outcomes are most likely to
succeed (Gard et al., 2009). Interestingly, the current participants
recognized that personal eﬀorts and hard work are instrumental
in regaining a sense of control, autonomy, and independence,
placing value in intrinsic motivation with the identiﬁcation of
personal goals that have real-world relevance and which underlie
recovery principles.
One possible motivation strategy makes use of group therapy
with its opportunity for sharing lessons from one’s journey and
to learn from each other. In support, in this study, the group
format as a methodological approach led to the exploration
of a broader range of issues relative to single interviews.
Of note, however, a subgroup of participants chose to have
individual interviews rather than a group session. While no key
diﬀerences in sleep themes emerged, personal contents were
more frequently brought up, with participants reporting a greater
number of adverse experiences (eﬀects of trauma, grief, and
loss on sleep, and detailed descriptions of nightmares). It is
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possible that these experiences were also common in the other
participants given that trauma is a common feature of psychosis
(Tarrier et al., 2007), but that the group format was not conducive
of such personal discussions. The current data does not provide
answers to this question, but our ﬁndings suggest that the
opportunity to have choices is important and that group therapy
may not suit everyone.
When asked their opinion regarding which treatment might
work best, participants explained that everyone is diﬀerent, and
that people need diﬀerent things at diﬀerent times. Cognitive
and behavioral approaches were perceived as more likely to
yield beneﬁts in the longer term, but they may not suit all
individuals especially if the person is experiencing lack of
insight, uncontrollable tiredness, or an acute episode of illness.
Eight participants thought that concurrent pharmacological and
psychological/behavioral interventions might be the optimal
approach during an episode of acute illness.
With regards limitations, the objective of the study was
to sample the views of people with psychosis in diﬀerent
environments, and participants included both psychiatric
inpatients and individuals in remission from psychotic disorders.
One consequence, therefore, is a small sample size in each of the
two groups, although this approach may arguably provide greater
methodological triangulation. The primary diﬀerence between
inpatients and outpatients was in the discussions by inpatients
about their sleep experiences in the hospital environment (e.g.,
help from nurses, sleeping walking amongst patients in the
wards). Another limitation is that individuals volunteered to
take part in this study possibly introducing a participant bias.
Finally, no participants had received CBT-I but all had used
pharmacological approaches and two had tried melatonin.
Participants had, therefore, informed views about antipsychotic
medications and sedatives, and were more likely to be aware
of their side eﬀects. By contrast, participants made ‘educated
guesses’ about the other treatments which may not reﬂect the
views of a personal experience of these interventions.
Conclusion
In light of evidence showing that poor sleep is intrinsically
linked to symptoms of psychosis and that it may act as a barrier
to recovery, it is becoming a clinical priority to fully address
sleep problems in people with psychotic disorders. In this study,
psychological and behavioral-type interventions and melatonin
were viewed as valid adjuncts to pharmacotherapy and there
was a strong desire for participants to make their own choices
regarding the type, and timing, of their therapies. This suggests
that psychological and behavioral treatments, including CBT-I,
should be more systematically oﬀered to people with psychosis
with co-occurring insomnia. In services without clinical expertise
in CBT-I, allied health professionals should oﬀer behavioral
interventions and education with an emphasis on good sleep
habits (a regular wake time, not clock watching, managing
caﬀeine and alcohol intake), awareness of sleep-promoting
activities such as regular exercise, association of the bedroom for
sleep only (removing TV, phones, etc, and not sleeping in living
areas), as well as relaxation and stress-management techniques
(Morin et al., 2006).
Overall, this study showed that clients seeking clinical care
for sleep problems must be consulted about their preferences
and views, and that engagement with others who share similar
experiences and an understanding of advantages and limitation of
diﬀerent interventions may be key elements to successful change.
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